The Pulse of the Pharmaceutical Industry
Akcea Therapeutics Inc. and Ionis Pharmaceuticals Inc. announced that Waylivra received conditional marketing authorization from the European Commission as the only therapy for FCS.
Read More »
Sorry. No data so far.
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!
© 2017 PharmaLive and Outcomes LLC